Mehmet Ozgur Zengin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mehmet Ozgur Zengin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Eyyup Karahan
Sifa University, Department of Ophthalmology, Izmir, Turkey
4 shared publications - Ibrahim Tuncer
Alfa Medical Center, Izmir, Turkey
3 shared publications Cem Kucukerdonmez
Izmir University Faculty of Medicine
2 shared publicationsEsat Cinar
Izmir University Faculty of Medicine
2 shared publicationsSami Yilmaz
Retina Eye Hospital
2 shared publicationsAli Sarpkaya
1 shared publication
Latest Publications
- 20 July 2015
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 37 (2) , 78-80
Haemorrhagic Conjunctival Retention Cyst
- 20 July 2015
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 37 (2) , 78-80
Haemorrhagic Conjunctival Retention Cyst
- 1 July 2015
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 98 (4) , 362-365
Correlation of choroidal thickness with serum cortisol level
Our results did not reveal any correlation between serum cortisol level and choroidal thickness. We believe that more prospective studies are needed to determine the relationship of cortisol and other hormones with choroidal thickness.
- 1 July 2015
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 98 (4) , 362-365
Correlation of choroidal thickness with serum cortisol level
Our results did not reveal any correlation between serum cortisol level and choroidal thickness. We believe that more prospective studies are needed to determine the relationship of cortisol and other hormones with choroidal thickness.
- 3 October 2014
- Published by Springer Nature in Eye
- Vol. 28 (12) , 1482-1487
Association of choroidal thickness with eye growth: a cross-sectional study of individuals between 4 and 23 years
We aimed to evaluate the association of subfoveal choroidal thickness (SFCT) with age and to determine its relationship with axial length (AL) and ocular biometric parameters, in children and young adults during growth period. One hundred and sixty patients (80 male, 80 female) aged between 4 and 23 years were included. Patients were classified into five groups according to their ages as group 1 (4-7 years of age), group 2 (8-11 years), group 3 (12-15 years), group 4 (16-19 years), and group 5 (20-23 years). SFCT was assessed using spectral-domain optical coherence tomography (3D OCT-2000). The measurements were taken at the same daytime (1000-1200 hours) to avoid diurnal fluctuation. Ocular AL and anterior segment parameters were measured using optical biometry (Lenstar LS900)). The average SFCT was 308.1±47.6 μm, ranging from 206 to 410 μm. The mean SFCT values in group 1 to 5 were measured as 306.8±42.0, 297.8±48.1, 283.2±38.9, 326.9±57.4, and 325.8±35.9 μm, respectively. The mean CT of group 3 was significantly thinner than group 4 and 5 (P<0.05 for two groups), however, there was no statistical significance compared with group 1 (P=0.227) and group 2 (P=0.693). On stepwise regression analysis, age exhibited a positive association with SFCT (B=2.8, P<0.001) and AL exhibited a negative association with choroidal thickness (B=-16.7, P<0.001). We found that SFCT shows no age-related difference until age of 15, whereas 16-23-year old participants had thicker SFCT compared with the younger ones. In that aspect, a thicker choroid associated with age in certain age groups suggests an age period of SFCT increase to a plateau in young adulthood. Larger studies are warranted to elucidate the age-related changes in SFCT in childhood, as improved evaluation of normal choroidal thicknesses during eye growth should assist in the diagnosis of choroidal abnormalities associated with eye disease.
- 3 October 2014
- Published by Springer Nature in Eye
- Vol. 28 (12) , 1482-1487
Association of choroidal thickness with eye growth: a cross-sectional study of individuals between 4 and 23 years
We aimed to evaluate the association of subfoveal choroidal thickness (SFCT) with age and to determine its relationship with axial length (AL) and ocular biometric parameters, in children and young adults during growth period. One hundred and sixty patients (80 male, 80 female) aged between 4 and 23 years were included. Patients were classified into five groups according to their ages as group 1 (4-7 years of age), group 2 (8-11 years), group 3 (12-15 years), group 4 (16-19 years), and group 5 (20-23 years). SFCT was assessed using spectral-domain optical coherence tomography (3D OCT-2000). The measurements were taken at the same daytime (1000-1200 hours) to avoid diurnal fluctuation. Ocular AL and anterior segment parameters were measured using optical biometry (Lenstar LS900)). The average SFCT was 308.1±47.6 μm, ranging from 206 to 410 μm. The mean SFCT values in group 1 to 5 were measured as 306.8±42.0, 297.8±48.1, 283.2±38.9, 326.9±57.4, and 325.8±35.9 μm, respectively. The mean CT of group 3 was significantly thinner than group 4 and 5 (P<0.05 for two groups), however, there was no statistical significance compared with group 1 (P=0.227) and group 2 (P=0.693). On stepwise regression analysis, age exhibited a positive association with SFCT (B=2.8, P<0.001) and AL exhibited a negative association with choroidal thickness (B=-16.7, P<0.001). We found that SFCT shows no age-related difference until age of 15, whereas 16-23-year old participants had thicker SFCT compared with the younger ones. In that aspect, a thicker choroid associated with age in certain age groups suggests an age period of SFCT increase to a plateau in young adulthood. Larger studies are warranted to elucidate the age-related changes in SFCT in childhood, as improved evaluation of normal choroidal thicknesses during eye growth should assist in the diagnosis of choroidal abnormalities associated with eye disease.
- 5 August 2014
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 44 (4) , 275-279
Nd: YAG Lazer Kapsülotominin Görme Keskinliği, Göz İçi Basıncı, Santral Kornea Kalınlığı ve Refraktif Duruma Etkisi
- 5 August 2014
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 44 (4) , 275-279
Nd: YAG Lazer Kapsülotominin Görme Keskinliği, Göz İçi Basıncı, Santral Kornea Kalınlığı ve Refraktif Duruma Etkisi
- 25 July 2014
- Published by Springer Nature in International Ophthalmology
- Vol. 35 (4) , 513-517
Choroidal thickness changes in patients with pseudoexfoliation syndrome
To evaluate the choroidal thickness using spectral-domain optical coherence tomography (OCT) in patients with pseudoexfoliation syndrome (PXS) and to compare them with healthy controls. This observational comparative study consisted of 35 PXS patients and 35 age- and sex-matched control cases. The control cases had neither systemic nor ocular disease. All 70 patients underwent a complete ophthalmic examination as well as choroidal thickness measurement using a high speed and high resolution SD-OCT device (Topcon 3D OCT-2000, Japan). There was no significant difference with respect to mean refractive error and intraocular pressure measurement between patients with PXS and controls (p = 0.237 and 0.433, respectively). The mean choroidal thickness was found as 206.6 ± 37.6 µm in the PXS group and 215.9 ± 47.3 µm in controls, respectively. The mean choroidal thickness was not significant between the PXS patients and the control cases (p = 0.362). Although PXS patients had lower mean choroidal thickness than controls, our results did not reach any statistical significance.
- 25 July 2014
- Published by Springer Nature in International Ophthalmology
- Vol. 35 (4) , 513-517
Choroidal thickness changes in patients with pseudoexfoliation syndrome
To evaluate the choroidal thickness using spectral-domain optical coherence tomography (OCT) in patients with pseudoexfoliation syndrome (PXS) and to compare them with healthy controls. This observational comparative study consisted of 35 PXS patients and 35 age- and sex-matched control cases. The control cases had neither systemic nor ocular disease. All 70 patients underwent a complete ophthalmic examination as well as choroidal thickness measurement using a high speed and high resolution SD-OCT device (Topcon 3D OCT-2000, Japan). There was no significant difference with respect to mean refractive error and intraocular pressure measurement between patients with PXS and controls (p = 0.237 and 0.433, respectively). The mean choroidal thickness was found as 206.6 ± 37.6 µm in the PXS group and 215.9 ± 47.3 µm in controls, respectively. The mean choroidal thickness was not significant between the PXS patients and the control cases (p = 0.362). Although PXS patients had lower mean choroidal thickness than controls, our results did not reach any statistical significance.
- 8 May 2014
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 115 (1) , 33-37
Choroidal thickness changes in patients with migraine
This observational study evaluated choroidal thickness using spectral domain optical coherence tomography (SD-OCT) in patients with migraine and compared the results with healthy controls. The study population consisted of 42 migraine patients (36 females and 6 males) who were referred from neurology clinics and 42 controls (36 female and 6 male) with no systemic or ocular disease and no headache of any type. All 84 patients underwent complete ophthalmic examination as well as determination of choroidal thickness using a high-speed, high-resolution SD-OCT device (λ = 840 nm, 27.000 A-scans/s, 5-µm axial resolution). The migraine patients were classified into the migraine with aura group or the migraine without aura group, and a pain score from 1 to 10 was determined for each patient based on the Visual Analogue Scale (VAS). The mean choroidal thicknesses were 276.81 ± 37.76 µm in the migraine group and 300.44 ± 24.93 µm in controls. The difference in choroidal thickness between the migraine patients and the controls was significant (P = 0.001). Choroidal thickness measurements of five patients during an attack showed an acute decrease (mean 45.50 µm) in choroidal thickness from the values in the same patients during the attack-free period. There was no correlation between VAS score and the type of migraine with choroidal thickness (P > 0.05). The decrease in mean choroidal thickness in patients with migraine compared to controls may be related to the vascular pathology of the migraine. The acute decrease in choroidal thickness during an attack also lends support to this hypothesis of reduced ocular blood flow in these patients.
- 8 May 2014
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 115 (1) , 33-37
Choroidal thickness changes in patients with migraine
This observational study evaluated choroidal thickness using spectral domain optical coherence tomography (SD-OCT) in patients with migraine and compared the results with healthy controls. The study population consisted of 42 migraine patients (36 females and 6 males) who were referred from neurology clinics and 42 controls (36 female and 6 male) with no systemic or ocular disease and no headache of any type. All 84 patients underwent complete ophthalmic examination as well as determination of choroidal thickness using a high-speed, high-resolution SD-OCT device (λ = 840 nm, 27.000 A-scans/s, 5-µm axial resolution). The migraine patients were classified into the migraine with aura group or the migraine without aura group, and a pain score from 1 to 10 was determined for each patient based on the Visual Analogue Scale (VAS). The mean choroidal thicknesses were 276.81 ± 37.76 µm in the migraine group and 300.44 ± 24.93 µm in controls. The difference in choroidal thickness between the migraine patients and the controls was significant (P = 0.001). Choroidal thickness measurements of five patients during an attack showed an acute decrease (mean 45.50 µm) in choroidal thickness from the values in the same patients during the attack-free period. There was no correlation between VAS score and the type of migraine with choroidal thickness (P > 0.05). The decrease in mean choroidal thickness in patients with migraine compared to controls may be related to the vascular pathology of the migraine. The acute decrease in choroidal thickness during an attack also lends support to this hypothesis of reduced ocular blood flow in these patients.
- 9 July 2013
- Published by Istanbul University in The Turkish Journal of Ear Nose and Throat
- Vol. 23 (4) , 207-210
Our endoscopic transcanalicular multidiode laser dacryocystorhinostomy results through bicanalicular silicone tube intubation
This study aims to evaluate the results of transcanalicular multidiode laser dacryocystorhinostomy (TMDL-DCR) through bicanalicular silicone tube intubation (BSTI). Between September 2011 and March 2012, treatment-naïve 43 eyes of 43 patients (24 males, 19 females; mean age 53.6±4.1 years; range 37 to 69 years) who presented with the complaint of watery eyes with a nasolacrimal duct obstruction and underwent TMDL-DCR through endoscopic silicone tube were included. Patients were assessed postoperatively. During follow-up, changes from baseline in signs and symptoms and the duration of intubation were recorded. The mean age of the patients was 53.6 years (range, 37 to 69 years). The mean follow-up was 19.4±2.2 months (range, 18 to 23 months). The mean duration of surgery was 16.5 min (range, 11 to 32 min). Epiphora was seen in seven patients following surgery. Nasolacrimal duct was open in 36 patients. The success rate was 83.7%. Transcanalicular multidiode laser DCR through BSTE is an effective and safe method in the management of nasolacrimal stenosis.
- 9 July 2013
- Published by Istanbul University in The Turkish Journal of Ear Nose and Throat
- Vol. 23 (4) , 207-210
Our endoscopic transcanalicular multidiode laser dacryocystorhinostomy results through bicanalicular silicone tube intubation
This study aims to evaluate the results of transcanalicular multidiode laser dacryocystorhinostomy (TMDL-DCR) through bicanalicular silicone tube intubation (BSTI). Between September 2011 and March 2012, treatment-naïve 43 eyes of 43 patients (24 males, 19 females; mean age 53.6±4.1 years; range 37 to 69 years) who presented with the complaint of watery eyes with a nasolacrimal duct obstruction and underwent TMDL-DCR through endoscopic silicone tube were included. Patients were assessed postoperatively. During follow-up, changes from baseline in signs and symptoms and the duration of intubation were recorded. The mean age of the patients was 53.6 years (range, 37 to 69 years). The mean follow-up was 19.4±2.2 months (range, 18 to 23 months). The mean duration of surgery was 16.5 min (range, 11 to 32 min). Epiphora was seen in seven patients following surgery. Nasolacrimal duct was open in 36 patients. The success rate was 83.7%. Transcanalicular multidiode laser DCR through BSTE is an effective and safe method in the management of nasolacrimal stenosis.
- 1 January 2010
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 40 (5) , 675-680
Does central corneal thickness correlate with haemoglobin A1c level and disease severity in diabetes type II?
To compare central corneal thickness (CCT) values of patients with type II diabetes mellitus with those of healthy subjects, and evaluate the effect of disease duration, retinopathy severity, and HbA1c level on CCT. Materials and methods: One hundred and twenty-six consecutive type II diabetic patients and 36 non-diabetic healthy subjects were included in the study. CCT was measured using the Orbscan II corneal topography system. The effect of disease duration, retinopathy severity, and HbA1c level on CCT was evaluated using analysis of variance (ANOVA) and the independent sample t test. Results: CCT was significantly higher in diabetic patients than in non-diabetic subjects. Severity of retinopathy and disease duration had no apparent effect on CCT. Diabetic patients with HbA1c levels over 7% had thicker corneas than patients with HbA1c levels under 7% (P = 0.021). Conclusion: Type II diabetic patients have thicker corneas than non-diabetic subjects. Higher HBA1c level may be a marker for predicting the increase in CCT in patients with type II diabetes.
- 1 January 2010
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 40 (5) , 675-680
Does central corneal thickness correlate with haemoglobin A1c level and disease severity in diabetes type II?
To compare central corneal thickness (CCT) values of patients with type II diabetes mellitus with those of healthy subjects, and evaluate the effect of disease duration, retinopathy severity, and HbA1c level on CCT. Materials and methods: One hundred and twenty-six consecutive type II diabetic patients and 36 non-diabetic healthy subjects were included in the study. CCT was measured using the Orbscan II corneal topography system. The effect of disease duration, retinopathy severity, and HbA1c level on CCT was evaluated using analysis of variance (ANOVA) and the independent sample t test. Results: CCT was significantly higher in diabetic patients than in non-diabetic subjects. Severity of retinopathy and disease duration had no apparent effect on CCT. Diabetic patients with HbA1c levels over 7% had thicker corneas than patients with HbA1c levels under 7% (P = 0.021). Conclusion: Type II diabetic patients have thicker corneas than non-diabetic subjects. Higher HBA1c level may be a marker for predicting the increase in CCT in patients with type II diabetes.